PS
CLB icon

Principal Securities’s Core Laboratories CLB Stock Holding History

Principal Securities’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-41
Closed -$507 – 1719
2025
Q3 		$507 Sell
41
-255
-86% -$2.99K ﹤0.01% 3532
2025
Q2 		$3.41K Buy
296
+47
+19% +$557 ﹤0.01% 2984
2025
Q1 		$4.31K Hold
249
– – ﹤0.01% 2822
2024
Q4 		$4.31K Sell
249
-18
-7% -$347 ﹤0.01% 2819
2024
Q3 		$4.95K Buy
267
+39
+17% +$783 ﹤0.01% 2681
2024
Q2 		$4.63K Hold
228
– – ﹤0.01% 2661
2024
Q1 		$3.89K Buy
228
+18
+9% +$283 ﹤0.01% 2685
2023
Q4 		$3.71K Buy
+210
New +$4.23K ﹤0.01% 2640

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Principal Securities's CLB Position: Q4 2025 in Review

Principal Securities sold out of Core Laboratories (CLB) in Q4 2025, closing a stake of 41 shares — an estimated $507 sold.

Principal Securities first reported a position in CLB in Q4 2023 and held it in 8 quarters. The position peaked at $4.95K in Q3 2024. 187 funds tracked by Wall St. Rank hold CLB as of Q4 2025.

  • Principal Securities reported no remaining Core Laboratories position as of Q4 2025 after selling out during the quarter.
  • Principal Securities sold 41 Core Laboratories shares in Q4 2025, an estimated $507.
  • Principal Securities first reported a position in Core Laboratories in Q4 2023 and held it in 8 quarters.
  • Principal Securities's Core Laboratories position peaked at $4.95K in Q3 2024.
  • 187 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2025.

Based on Principal Securities's 13F filing for Q4 2025, filed 12 Feb 2026.